Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interactions between endothelial mediators

R J Gryglewski1

  • 1Institute of Pharmacology, Medical College of Jagiellonian University, Cracow, Poland.

Pharmacology & Toxicology
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo endothelial interaction between ACE and COX inhibitors.

Prostaglandins, leukotrienes, and essential fatty acids·2005
Same author

Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart.

Prostaglandins, leukotrienes, and essential fatty acids·2005
Same author

Clonidine-induced coronary vasodilatation in isolated guinea pig heart is not mediated by endothelial alpha2 adrenoceptors.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2004
Same author

Flavonoids and nitric oxide synthase.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2003
Same author

No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5 HT1A-receptors.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2003
Same author

Synthesis and thrombolytic activity of new thienopyrimidinone derivatives.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2003

Endothelial cells release key mediators: prostacyclin, nitric oxide, and tissue plasminogen activator. These substances interact to regulate vascular health, influencing thrombosis, tone, and fibrinolysis.

Area of Science:

  • Vascular Biology
  • Endothelial Cell Function
  • Biomedical Science

Background:

  • Endothelial cells produce critical mediators: prostacyclin (PGI2), nitric oxide (NO), and tissue plasminogen activator (tPA).
  • These mediators play vital roles in maintaining vascular homeostasis, including thromboresistance, vascular tone, and fibrinolysis.
  • Receptor agonists trigger the release of these endothelial mediators.

Purpose of the Study:

  • To explore the synergistic and antagonistic interactions among prostacyclin, nitric oxide, and tissue plasminogen activator.
  • To understand the evolutionary relationship of these endothelial mediators.
  • To highlight the potential implications for understanding vascular diseases.

Main Methods:

  • Review and synthesis of existing literature on endothelial mediators.

Related Experiment Videos

  • Analysis of the functional roles and interactions of PGI2, NO, and tPA.
  • Filogenetic comparison of the regulatory properties of these mediators.

    • Main Results:

    • PGI2 maintains vascular thromboresistance, inhibits smooth muscle proliferation, and modulates cholesterol.
    • tPA is a key fibrinolytic agent, while NO regulates vascular tone and structure.
    • PGI2 and NO exhibit synergistic antiplatelet, fibrinolytic, and cardioprotective effects, but not hypotensive effects.
    • PGI2, unlike NO, prevents paradoxical thrombogenic effects of tPA.
    • PGI2 and tPA are viewed as phylogenetically younger mediators that evolved from NO's regulatory functions.

    Conclusions:

    • The interplay between PGI2, NO, and tPA is crucial for vascular health.
    • Understanding these interactions is vital for deciphering the pathophysiology of thrombosis, atherogenesis, and hypertension.
    • Further research into endothelial mediator interactions may yield therapeutic insights for vascular diseases.